If you don’t have control over your data, you don’t have control over your practice. The world of healthcare has become more and more data driven for measuring efficiency, quality and many are relying exclusively on insurance claims data and not clinical data. Frier Levitt Co-Founder Daniel B. Frier, Esq. was joined by New York City Office Managing Partner John E. Morrone, Esq. and Associate Arielle T. Miliambro, Esq. last week for “How Physicians Can Extract Value From Their Own Clinical and Claims Data Through Data Aggregation.”
This topic addresses the growing value of claims and clinical data to Big Pharma and other stakeholders, and details how hospitals, medical practices and other provider organizations can commercialize their data both through licensing agreements and value-based contracting. It also addresses the types of raw data, both structured and unstructured, as well as the process of normalizing, aggregating and curating data. It covers how to structure and negotiate data contracts, and how to avoid inadvertently giving up valuable data rights. The presentation also reveals potential regulatory pitfalls in data transactions, and the importance and complexity of obtaining a fair market valuation of data. Finally, our presenters incorporate certain elements of HIPAA in the context of data licensing agreements.
Access this complimentary webinar “How Physicians Can Extract Value From Their Own Clinical and Claims Data Through Data Aggregation” now by filling out the form below: